Vimentin, Human Recombinant
VIM
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P08670 |
---|---|
Calculated MW | 54.3 kDa |
Gene ID | 7431 |
---|---|
Other Names | VIM |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE;≥95% |
Assay2&Purity2 | HPLC;≥95% |
Recombinant | Yes |
Sequence | Full length of human Vimentin with a 6-residue C-terminal His-Tag |
Target/Specificity | Vimentin |
Application Notes | Reconstitute in sterile deionized water to a concentration of 0.1-1.0 mg/ml. Do not vortex. Additional carrier protein (example 0.1% BSA) is recommended for long term storage. |
Format | Dry powder |
Storage | -80°C;Lyophilized powder |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.